Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention
- 15 May 2009
- journal article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 103 (10), 1339-1343
- https://doi.org/10.1016/j.amjcard.2009.01.341
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Clopidogrel and Calcium-Channel Antagonists: Another Drug–Drug Interaction for the Ever-Wary Clinician?Journal of the American College of Cardiology, 2008
- Point-of-Care Measurement of Clopidogrel Responsiveness Predicts Clinical Outcome in Patients Undergoing Percutaneous Coronary Intervention: Results of the ARMYDA-PRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) StudyJournal of the American College of Cardiology, 2008
- Elevated Plasma Fibrinogen and Diabetes Mellitus Are Associated With Lower Inhibition of Platelet Reactivity With ClopidogrelJournal of the American College of Cardiology, 2008
- Relation of Low Response to Clopidogrel Assessed With Point-of-Care Assay to Periprocedural Myonecrosis in Patients Undergoing Elective Coronary Stenting for Stable Angina PectorisThe American Journal of Cardiology, 2008
- Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal StentsJournal of the American College of Cardiology, 2008
- Effect of Cytochrome P450 Polymorphisms on Platelet Reactivity After Treatment With Clopidogrel in Acute Coronary SyndromeThe American Journal of Cardiology, 2008
- Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantationEuropean Heart Journal, 2008
- The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationThrombosis and Haemostasis, 2008
- Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjectsBlood, 2006
- Validation of a VerifyNow-P2Y12 cartridge for monitoring platelet inhibition with clopidogrelMethods and Findings in Experimental and Clinical Pharmacology, 2006